ALK-positive large B-cell lymphoma
ALK-positive large B-cell lymphoma
Explore linked clinical trials. Standard reference: MONDO:00182253 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma | ALK-positive large B-cell lymphoma, B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell/histiocyte rich large B cell lymphoma, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, primary mediastinal large B-cell lymphoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT04231877 | |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas | ALK-positive large B-cell lymphoma, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, diffuse large B-cell lymphoma, diffuse large B-cell lymphoma activated B-cell type, diffuse large B-cell lymphoma germinal center B-cell type, diffuse large B-cell lymphoma of the central nervous system, immune system disorder, immunoproliferative disorder, intravascular large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphomatoid granulomatosis, lymphoproliferative syndrome, neoplasm, plasmablastic lymphoma, precancerous condition, primary effusion lymphoma, viral infectious disease | Active, not recruiting | Phase 2 | 2026-05-12 | NCT03038672 | |
| Study of SGR-1505 in Mature B-Cell Neoplasms | ALK-positive large B-cell lymphoma, B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell/histiocyte rich large B cell lymphoma, Tumor Virus Infections, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, digestive system disorder, follicular lymphoma, hematologic disorder, hemorrhagic disease, high grade B-cell lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoplasmacytic lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, monoclonal gammopathy, neoplasm, neoplasm of mature B-cells, nodal marginal zone B-cell lymphoma, non-Hodgkin lymphoma, plasma cell neoplasm, plasmablastic lymphoma, primary cutaneous follicle center lymphoma, primary effusion lymphoma, pyloric stenosis, splenic marginal zone lymphoma, stomach disorder, vascular disorder, vascular hemostatic disease, viral infectious disease | Recruiting | Phase 1 | 2026-02-13 | NCT05544019 |